1. Sanaa Zebakh, Jaouad Anissi, Salim BOUNOU . Indicators from patent data: The contribution of Moroccan higher education and research institutions to innovation in the agricultural field. Submitted to Scientometrics. June 2020. IF: 2.7
2. Côté SC, Pasvanis S, Bounou S, Dumais N. CCR7-specific migration to CCL19 and CCL21 is induced by PGE(2) stimulation in human monocytes: Involvement of EP(2)/EP(4) receptors activation.  Mol Immunol . 2009 Aug;46(13):2682-93. Epub 2009 Jul 9 . FI: 3.1
3. Boisvert M, Côté S, Vargas A, Pasvanis S, Bounou S, Barbeau B, Dumais N. PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells.  Virology . 2008 Oct 10;380(1):1-11. Epub 2008 Aug 27 . IF: 2.59
4. Michel Ouellet,* Simon Mercier,* Isabelle Pelletier,† Salim Bounou,* Jocelyn Roy,* Jun Hirabayashi,‡ Sachiko Sato,2† and Michel J. Tremblay2*2005. Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J. Immunol.  2005 Apr 1;174(7):4120-6. IF: 6.8
5. Bounou, S., Giguère, J.-F., Cantin, R., Gilbert, C., Imbeault, M., Martin G., Tremblay, MJ, 2004. The importance of virus-bound host ICAM-1 in HIV -1 transfer depends on the cellular context. FASEB J. 2004 Aug 1, 2004;  18 (11). IF: 6.88
6. Salim Bounou* , Jean-François Giguère*, Jean-Sébastien Paquette and Michel J. Tremblay 2004. Incorporation of host CD80 (B7.1) and CD86 (B7.2) glycoproteins into HIV-1 increases viral infectivity in primary human mononuclear cells . J Virol.  2004 Jun;78(12):6222-32. IF: 5.54          *Co-first author
7. Dumais N, Pare ME, Mercier S, Bounou S, Marriot SJ, Barbeau B, Tremblay MJ., 2003. T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment lead to potent activation of human T-cell leukemia virus type transcription . J Virol. 2003 Oct 15;77(20):11170-11179. IF: 5.54
8. Jean-François Giguère, Jean-Sébastien Paquette, Salim Bounou , and Michel J. Tremblay, 2002. New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus human immunodeficiency virus type 1. J. Immunol. 2002 Sep 1;169(5):2762-71. FI: 7.01
9. Bounou, Jacques E. Leclerc, and Michel. J. Tremblay, 2002. The presence of host ICAM-1 in laboratory and clinical strains of HIV-1 increases virus infectivity and CD4+ T-cell depletion in human lymphoid tissue, a major site of replication in vivo . J. Virol. 2002 Feb 1;76(3):1004-1014. FI: 5.54
10. Nancy Dumais, Salim Bounou , Martin Olivier and Michel J. Tremblay, 2002. The CCAAT/Enhancer-binding protein is required for mediating cAMP responsiveness on HIV-1 LTR-driven gene activity in T cells mediated by prostaglandin E2. J. Immunol. 2002 Jan 1;168(1):274-82. FI: 7.01
11. Salim Bounou , Dumais Nancy, Tremblay Michel J, 2001 . Attachment of HIV-1 particles bearing host-encoded B7-2 proteins leads to NF-B- and NFAT-dependent activation of HIV-1 LTR transcription. J Biol Chem. 2001 Mar 2;276(9):6359-69. FI: 6.69
12. Salim Bounou , Suha H. Jabaji-Hare, Richard Hogue and Pierre M. Charest, 1999. Polymerase chain reaction-based assay for specific detection of Rhizoctonia solani AG-3 isolates. Mycological Research Vol 103, part 1, p.1-8. IF: 1.52

WORKING Paper:

1. Benmoussa Othmane, Slighoua Mounia, Gmira Maha, and Bounou, Salim . The SARS-CoV-2 Pandemic Management: The Case of Morocco. Euro-Mediterranean Network for Economic Studies. EMNES Working Paper No33/June, 2020.
2. Benmoussa Othmane, Slighoua Mounia, Bachiri Housseine, Bounou Salim . Entrepreneurship and Traditional Know-How: The Case of Moroccan Rural Women. Benmoussa Othmane, Slighoua Mounia, Bachiri Housseine, Bounou Salim . Euro-Mediterranean Network for Economic Studies. EMNES WORKING PAPER / June, 2019 under edition.

Conferences and Seminars

1. Innovation and valorization of research-Legal elements. MedBiotech Conferences. Faculty of Medicine and Pharmacy of Rabat, Morocco, December 19, 2019.

2. The different types of public research contracts - business and transfers, Licensing agreements - The basics of negotiation. CNRST, Rabat, Morocco. October 31 and November 1, 2019.

3. The legal elements of research valorization. CNRST, Rabat, Morocco. July 23, 2016

4. First analysis of potential innovation and assessment of needs to improve valorization of research results. ARIMNET. June 11, 2014 - Campus de la Gaillarde INRA-SupAgro, Montpellier, France.

5. Knowledge enhancement and technology transfer. June 30, 2012, Moroccan Medical Skills of the World (C3M) & Faculty of Medicine of Casablanca, Morocco.

6. Technological valorization and spin-off: Point of view from the University of Sherbrooke. Day on the valorization of research results.  Mohammed V-Souissi University, May 7, 2009, Rabat, Morocco .

7. Maintain competitive advantage through innovation. October 23, 2008, IBM-Bromont, Canada .

8. Management of intellectual property and commercialization of research products at the University of Sherbrooke. Faculty of Administration, University of Sherbrooke, May 20, 2008, Sherbrooke, Canada and Touraine Board of Trade - Chamber of Commerce Touraine.

9. New therapeutic strategy to counter bacterial and viral infections. A Biopharmaceutical Partnership Symposium, special meeting of industry leaders, October 3, 2007, Château Frontenac, Quebec, Canada.

10. Plasminic biosensor based on semiconductor. Workshop on innovating industrial processes applied to new materials Hotel DELTA, October 2nd, 2007, Sherbrooke, Canada.

11. An device for rapid detection of infectious agents. The Canadian Institute for Photonic Innovations, a Network of Centers of Excellence. October 20th, 2006, Montreal, Canada.

12. Host Proteins incorporated in HIV envelope: Pathogenesis. Health Products and Food Branch, Bureau of Microbial Hazards, Health Canada, Sir Frederick G. Banting Research Centre, Tunney's Pasture, PL 2204A2, February 15, 2005, Ottawa, Ontario. Canada.

13. Host molecules incorporated into the HIV-1 envelope: Pathogenesis of infection. Inflammation Research Center, Center Hospitalier de l'Université de Sherbrooke (CHUS), January 13, 2003, Sherbrooke, Canada.

14. Host molecules incorporated into the HIV-1 envelope: Incorporation of the ICAM-1 molecule-Pathogenesis of infection. Center Hospitalier Universitaire de Montréal (CHUM), University of Montreal, July 26, 2002, Montreal, Canada.

15. Host Proteins incorporated in HIV envelope: Pathogenesis. Center for Biomedical Research, Population Council, Rockefeller University, April 30, 2002, New York, USA.

16. HIV infection: host proteins incorporated in the envelope oh HIV-1. National Institute of Scientific Research in Health (INRS-Santé), Jun 22, 2001, Pointe-Claire, Quebec, Canada.

17. Role of host molecules in the pathogenesis of HIV infection. Dhar Mehraz Faculty of Sciences, Sidi Mohammed Ben Abdallah University, November 21, 2000, FES, MOROCCO.